Literature DB >> 25226064

Primary culture of mouse dopaminergic neurons.

Florence Gaven1, Philippe Marin1, Sylvie Claeysen2.   

Abstract

Dopaminergic neurons represent less than 1% of the total number of neurons in the brain. This low amount of neurons regulates important brain functions such as motor control, motivation, and working memory. Nigrostriatal dopaminergic neurons selectively degenerate in Parkinson's disease (PD). This progressive neuronal loss is unequivocally associated with the motors symptoms of the pathology (bradykinesia, resting tremor, and muscular rigidity). The main agent responsible of dopaminergic neuron degeneration is still unknown. However, these neurons appear to be extremely vulnerable in diverse conditions. Primary cultures constitute one of the most relevant models to investigate properties and characteristics of dopaminergic neurons. These cultures can be submitted to various stress agents that mimic PD pathology and to neuroprotective compounds in order to stop or slow down neuronal degeneration. The numerous transgenic mouse models of PD that have been generated during the last decade further increased the interest of researchers for dopaminergic neuron cultures. Here, the video protocol focuses on the delicate dissection of embryonic mouse brains. Precise excision of ventral mesencephalon is crucial to obtain neuronal cultures sufficiently rich in dopaminergic cells to allow subsequent studies. This protocol can be realized with embryonic transgenic mice and is suitable for immunofluorescence staining, quantitative PCR, second messenger quantification, or neuronal death/survival assessment.

Entities:  

Mesh:

Year:  2014        PMID: 25226064      PMCID: PMC4828056          DOI: 10.3791/51751

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  36 in total

1.  Pitx3 is required for development of substantia nigra dopaminergic neurons.

Authors:  Irene Nunes; Lucy T Tovmasian; Robert M Silva; Robert E Burke; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

Review 2.  Presynaptic regulation of dopaminergic transmission in the striatum.

Authors:  J Glowinski; A Chéramy; R Romo; L Barbeito
Journal:  Cell Mol Neurobiol       Date:  1988-03       Impact factor: 5.046

3.  The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis.

Authors:  Erwann Rousseau; Patrick P Michel; Etienne C Hirsch
Journal:  Mol Pharmacol       Date:  2013-09-27       Impact factor: 4.436

4.  Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.

Authors:  Xian Lin; Loukia Parisiadou; Carmelo Sgobio; Guoxiang Liu; Jia Yu; Lixin Sun; Hoon Shim; Xing-Long Gu; Jing Luo; Cai-Xia Long; Jinhui Ding; Yolanda Mateo; Patricia H Sullivan; Ling-Gang Wu; David S Goldstein; David Lovinger; Huaibin Cai
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

5.  Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson's disease.

Authors:  Loréline Jouve; Pascal Salin; Christophe Melon; Lydia Kerkerian-Le Goff
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

Review 6.  Dopaminergic neurons.

Authors:  Shankar J Chinta; Julie K Andersen
Journal:  Int J Biochem Cell Biol       Date:  2004-12-02       Impact factor: 5.085

7.  Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.

Authors:  Emanuela Santini; Myriam Heiman; Paul Greengard; Emmanuel Valjent; Gilberto Fisone
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

8.  Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.

Authors:  Hui-Ming Gao; Bin Liu; Wanqin Zhang; Jau-Shyong Hong
Journal:  FASEB J       Date:  2003-08-01       Impact factor: 5.191

9.  A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation.

Authors:  I Marey-Semper; M Gelman; M Lévi-Strauss
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

10.  Dopaminergic axon guidance: which makes what?

Authors:  Laetitia Prestoz; Mohamed Jaber; Afsaneh Gaillard
Journal:  Front Cell Neurosci       Date:  2012-07-31       Impact factor: 5.505

View more
  15 in total

1.  Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons.

Authors:  Angela Cruz-Hernandez; Zeynep Sena Agim; Paola C Montenegro; George P McCabe; Jean-Christophe Rochet; Jason R Cannon
Journal:  Neurotoxicology       Date:  2018-03       Impact factor: 4.294

Review 2.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

3.  Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.

Authors:  Kwang Soo Kim; Paul C Marcogliese; Jungwoo Yang; Steve M Callaghan; Virginia Resende; Elizabeth Abdel-Messih; Connie Marras; Naomi P Visanji; Jana Huang; Michael G Schlossmacher; Laura Trinkle-Mulcahy; Ruth S Slack; Anthony E Lang; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

Review 4.  Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.

Authors:  Kathrin Meyer; Brian K Kaspar
Journal:  Brain Res       Date:  2016-01-09       Impact factor: 3.252

Review 5.  Cellular models of alpha-synuclein toxicity and aggregation.

Authors:  Marion Delenclos; Jeremy D Burgess; Agaristi Lamprokostopoulou; Tiago F Outeiro; Kostas Vekrellis; Pamela J McLean
Journal:  J Neurochem       Date:  2019-07-30       Impact factor: 5.372

Review 6.  Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research.

Authors:  Martin Engel; Dzung Do-Ha; Sonia Sanz Muñoz; Lezanne Ooi
Journal:  Cell Mol Life Sci       Date:  2016-05-06       Impact factor: 9.261

7.  ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease.

Authors:  Masaki Nakano; Hiromi Imamura; Norio Sasaoka; Masamichi Yamamoto; Norihito Uemura; Toshiyuki Shudo; Tomohiro Fuchigami; Ryosuke Takahashi; Akira Kakizuka
Journal:  EBioMedicine       Date:  2017-07-25       Impact factor: 8.143

Review 8.  In vitro Models of Neurodegenerative Diseases.

Authors:  Anna Slanzi; Giulia Iannoto; Barbara Rossi; Elena Zenaro; Gabriela Constantin
Journal:  Front Cell Dev Biol       Date:  2020-05-13

9.  An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system.

Authors:  Yoon-Jin Kim; Qingyao Kong; Soh Yamamoto; Kenta Kuramoto; Mei Huang; Nan Wang; Jung Hwa Hong; Tong Xiao; Beth Levine; Xianxiu Qiu; Yanxiang Zhao; Richard J Miller; Hongxin Dong; Herbert Y Meltzer; Ming Xu; Congcong He
Journal:  Sci Adv       Date:  2021-02-19       Impact factor: 14.136

10.  Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1.

Authors:  Hanyu Yang; Lu Wang; Caixia Zang; Xu Yang; Xiuqi Bao; Junmei Shang; Zihong Zhang; Hui Liu; Cheng Ju; Fangyuan Li; Fangyu Yuan; Dan Zhang
Journal:  Front Pharmacol       Date:  2021-03-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.